Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving 177LuLu-DOTATATE

Recent reports personalizing the administered activity (AA) of each cycle of peptide receptor radionuclide therapy based on the predicted absorbed dose (AD) to the kidneys (dose-limiting organ) have been promising. Assuming identical renal pharmacokinetics for each cycle is pragmatic, however it may...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	EJNMMI physics 2022-03, Vol.9 (1), p.24
Hauptverfasser:	Malcolm, Javian C, Falzone, Nadia, Gains, Jennifer E, Aldridge, Matthew D, Mirando, David, Lee, Boon Q, Gaze, Mark N, Vallis, Katherine A
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!